Inside Access, Outside the Rules - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Inside Access, Outside the Rules

Two federal cases highlight alleged misuse of professional roles in health care settings

  • By

  • Kerri Miller

  • April 1, 2026

  • 3 min

Share

Clinical Scorecard: Inside Access, Outside the Rules

At a Glance

CategoryDetail
ConditionPharmacy Diversion Risk and Telemedicine Fraud
Key MechanismsIllegal acquisition of controlled substances and fraudulent Medicare billing practices.
Target PopulationPharmacists and telemedicine patients, particularly Medicare beneficiaries.
Care SettingPharmacy and telemedicine environments.

Key Highlights

  • Pharmacist indicted for diverting controlled substances from employer.
  • Telemedicine company owner pleads guilty to $46M Medicare fraud scheme.
  • Fraudulent practices included patient recruitment and billing for unnecessary items.
  • Indicted individuals presumed innocent until proven guilty.
  • Regulatory tensions highlighted in telemedicine oversight.

Guideline-Based Recommendations

Diagnosis

  • Monitor for signs of substance diversion in pharmacy settings.
  • Assess telemedicine practices for compliance with regulations.

Management

  • Implement strict controls and audits in pharmacies handling controlled substances.
  • Enhance oversight of telemedicine billing practices.

Monitoring & Follow-up

  • Regularly review pharmacy operations for potential diversion risks.
  • Conduct audits of telemedicine claims and patient interactions.

Risks

  • Potential for substance abuse and legal repercussions for pharmacists.
  • Financial and legal risks associated with fraudulent billing in telemedicine.

Patient & Prescribing Data

Medicare beneficiaries and patients receiving controlled substances.

Patients may be subjected to unnecessary treatments or prescriptions due to fraudulent practices.

Clinical Best Practices

  • Establish clear protocols for handling controlled substances in pharmacies.
  • Ensure meaningful patient-physician interactions in telemedicine.

Related Resources & Content

Original Source(s)

Inside Access, Outside the Rules

  • by Kerri Miller

  • April 1, 2026

Related Content

CDC Updates Cyclosporiasis Surveillance

More than 5,100 additional reports require further analysis as federal and state partners investigate several outbreaks and work to identify their sources.

FDA Approves Treg Cell Therapy

A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.

Can Consumer Wearables Support PASC Monitoring?

Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.